Cargando…

Posterior atrophy predicts time to dementia in patients with amyloid-positive mild cognitive impairment

BACKGROUND: In patients with amyloid-positive mild cognitive impairment (MCI), neurodegenerative biomarkers such as medial temporal lobe atrophy (MTA) are useful to predict disease progression to dementia. Although posterior atrophy (PA) is a well-known neurodegenerative biomarker of Alzheimer’s dis...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pyun, Jung-Min, Park, Young Ho, Kim, Hang-Rai, Suh, Jeewon, Kang, Min Ju, Kim, Beom Joon, Youn, Young Chul, Jang, Jae-Won, Kim, SangYun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5732486/ https://www.ncbi.nlm.nih.gov/pubmed/29246250 http://dx.doi.org/10.1186/s13195-017-0326-y

Ejemplares similares

A ‘Comprehensive Visual Rating Scale’ for predicting progression to dementia in patients with mild cognitive impairment
por: Jang, Jae-Won, et al.
Publicado: (2018)

Change in cognitive function according to cholinesterase inhibitor use and amyloid PET positivity in patients with mild cognitive impairment
por: Pyun, Jung-Min, et al.
Publicado: (2021)

Coping with Dementia in the Middle of the COVID-19 Pandemic
por: Ryoo, Nayoung, et al.
Publicado: (2020)

Integration of amyloid-β oligomerization tendency as a plasma biomarker in Alzheimer's disease diagnosis
por: Pyun, Jung-Min, et al.
Publicado: (2023)

Medial Temporal Atrophy and Memory Dysfunction in Poststroke Cognitive Impairment-No Dementia
por: Kim, Beom Joon, et al.
Publicado: (2012)

Misplacement of something inside the refrigerator is not a sign of dementia, but a probable symptom of attention deficit due to depression
por: Suh, Jeewon, et al.
Publicado: (2021)

Predictability of polygenic risk score for progression to dementia and its interaction with APOE ε4 in mild cognitive impairment
por: Pyun, Jung-Min, et al.
Publicado: (2021)

Blood amyloid-β oligomerization associated with neurodegeneration of Alzheimer’s disease
por: Youn, Young Chul, et al.
Publicado: (2019)

Dysregulated expression levels of APH1B in peripheral blood are associated with brain atrophy and amyloid-β deposition in Alzheimer’s disease
por: Park, Young Ho, et al.
Publicado: (2021)

Prediction of amyloid PET positivity via machine learning algorithms trained with EDTA-based blood amyloid-β oligomerization data
por: Youn, Young Chul, et al.
Publicado: (2022)

Driving Cessation and Cognitive Dysfunction in Patients with Mild Cognitive Impairment
por: Pyun, Jung-Min, et al.
Publicado: (2018)

Plasma Amyloid-β Oligomerization Tendency Predicts Amyloid PET Positivity
por: Pyun, Jung-Min, et al.
Publicado: (2021)

Differences between memory encoding and retrieval failure in mild cognitive impairment: results from quantitative electroencephalography and magnetic resonance volumetry
por: Han, Su-Hyun, et al.
Publicado: (2021)

Amyloid-independent atrophy patterns predict time to progression to dementia in mild cognitive impairment
por: ten Kate, Mara, et al.
Publicado: (2017)

Predictive Scale for Amyloid PET Positivity Based on Clinical and MRI Variables in Patients with Amnestic Mild Cognitive Impairment
por: Chun, Min Young, et al.
Publicado: (2022)

Association of a History of Sleep Disorder With Risk of Mild Cognitive Impairment and Alzheimer’s Disease Dementia
por: Choe, Young Min, et al.
Publicado: (2022)

Cost-effectiveness of using amyloid positron emission tomography in individuals with mild cognitive impairment
por: Lee, Young-Sil, et al.
Publicado: (2021)

Supernumerary phantom limb in a patient with basal ganglia hemorrhage - a case report and review of the literature
por: Kim, Hang-Rai, et al.
Publicado: (2017)

Predicting progression to dementia with “comprehensive visual rating scale” and machine learning algorithms
por: Park, Chaeyoon, et al.
Publicado: (2022)

The Validity and Reliability of the Mini-Mental State Examination-2 for Detecting Mild Cognitive Impairment and Alzheimer’s Disease in a Korean Population
por: Baek, Min Jae, et al.
Publicado: (2016)

A Comprehensive Visual Rating Scale for Predicting Progression from Mild Cognitive Impairment to Dementia in Patients with Alzheimer's Pathology or Suspected Non-Alzheimer's Pathology
por: Park, Sang Won, et al.
Publicado: (2020)

The impact of subthreshold levels of amyloid deposition on conversion to dementia in patients with amyloid-negative amnestic mild cognitive impairment
por: Kim, Hyung-Ji, et al.
Publicado: (2022)

Prediction of conversion to dementia using interpretable machine learning in patients with amnestic mild cognitive impairment
por: Chun, Min Young, et al.
Publicado: (2022)

Abstract Word Definition in Patients with Amnestic Mild Cognitive Impairment
por: Kim, Soo Ryon, et al.
Publicado: (2015)

Pathogenic PSEN1 Thr119Ile Mutation in Two Korean Patients with Early-Onset Alzheimer’s Disease
por: Bagyinszky, Eva, et al.
Publicado: (2020)

Psychometric properties of the geriatric quality of life-dementia in older adults with dementia or mild cognitive impairment living in nursing homes
por: Park, Eun-Young, et al.
Publicado: (2019)

P300 latency changes in patients with mild cognitive impairment after taking choline alphoscerate; A preliminary study
por: Han, Su-Hyun, et al.
Publicado: (2018)

Comparison of neurodegenerative types using different brain MRI analysis metrics in older adults with normal cognition, mild cognitive impairment, and Alzheimer’s dementia
por: Choi, Myungwon, et al.
Publicado: (2019)

Amyloid and tau positive mild cognitive impairment: clinical and biomarker characteristics of dementia progression
por: Wei, Hong-Chun, et al.
Publicado: (2021)

Differential White Matter Connectivity in Early Mild Cognitive Impairment According to CSF Biomarkers
por: Lim, Jae-Sung, et al.
Publicado: (2014)

Improvement of Screening Accuracy of Mini-Mental State Examination for Mild Cognitive Impairment and Non-Alzheimer's Disease Dementia by Supplementation of Verbal Fluency Performance
por: Kim, Jee Wook, et al.
Publicado: (2014)

Oligomeric forms of amyloid-β protein in plasma as a potential blood-based biomarker for Alzheimer’s disease
por: Wang, Min Jeong, et al.
Publicado: (2017)

Clinical, FDG and amyloid PET imaging in posterior cortical atrophy
por: Singh, Tarun D., et al.
Publicado: (2015)

Prediction of Amyloid Positivity in Mild Cognitive Impairment Using Fully Automated Brain Segmentation Software
por: Kang, Koung Mi, et al.
Publicado: (2020)

Dynamic changes of oligomeric amyloid β levels in plasma induced by spiked synthetic Aβ(42)
por: An, Seong Soo A., et al.
Publicado: (2017)

Predictors of pre-operative cognitive impairment in meningioma patients over 60 years old
por: Kang, Min Ju, et al.
Publicado: (2020)

Early Onset Alzheimer's Disease Presenting as Logopenic Primary Progressive Aphasia
por: Oh, Mi Jin, et al.
Publicado: (2018)

Homonymous Hemianopia as the Initial Sign of Posterior Cortical Atrophy
por: Kim, Chung Young, et al.
Publicado: (2019)

Associations of rest-activity patterns with amyloid burden, medial temporal lobe atrophy, and cognitive impairment
por: Roh, Hyun Woong, et al.
Publicado: (2020)

MMSE Subscale Scores as Useful Predictors of AD Conversion in Mild Cognitive Impairment
por: Choe, Young Min, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_6pn0ps56k8cnaab5kpg188gi9e